Cargando…
Antidiabetes Agents against Sars-Cov-2 Infection
People with chronic diseases represent a population at major risk of infection and complications from Sars-Cov-2 (COVID-19). Diabetes represents one of the most important comorbidities related to the severity of viral infection caused by the new Sars-Cov-2. Diabetes patients have a higher risk of se...
Autores principales: | Vitiello, Antonio, Ferrara, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585556/ https://www.ncbi.nlm.nih.gov/pubmed/33134845 http://dx.doi.org/10.1007/s42399-020-00608-2 |
Ejemplares similares
-
Worldwide Recommendations and Therapies for Multiple Sclerosis: Are They Safe in the COVID-19 Pandemic Period?
por: Ferrara, Francesco, et al.
Publicado: (2020) -
The Central Role of Clinical Nutrition in COVID-19 Patients During and After Hospitalization in Intensive Care Unit
por: Ferrara, Francesco, et al.
Publicado: (2020) -
COVID-19 Patients with Pulmonary Fibrotic Tissue: Clinical Pharmacological Rational of Antifibrotic Therapy
por: Vitiello, Antonio, et al.
Publicado: (2020) -
First motor seizure as presenting symptom of SARS-CoV-2 infection
por: Fasano, Antonio, et al.
Publicado: (2020) -
COVID‐19 elicits an impaired antibody response against SARS‐CoV‐2 in patients with haematological malignancies
por: Passamonti, Francesco, et al.
Publicado: (2021)